FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.8-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000489007: Concept inactivation indicator attribute value reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001066017 Concept inactivation indicator attribute value reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001067014 Concept inactivation indicator reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001068016 Concept inactivation indicator attribute value reference set (foundation metadata concept) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


141007 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Concept inactivation indicator reference set Is a Attribute value type true Inferred relationship Some

Members valueId
Ceftazidime 6g/vial injection A component that fails to comply with the current editorial guidance.
Ceftazidime 6g/vial powder A component that fails to comply with the current editorial guidance.
Ceftazidime 6g/vial powder for injection A component that fails to comply with the current editorial guidance.
Ceftazidime overdose of undetermined intent A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Ceftazidime pentahydrate 100mg infusion solution vial A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime pentahydrate 1g injection A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime pentahydrate 1g/vial injection A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime pentahydrate 2g injection A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime pentahydrate 2g powder for injection A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime pentahydrate 2g/vial injection A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime pentahydrate 6g infusion solution vial A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime pentahydrate 6g injection A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime pentahydrate 6g/vial injection A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime poisoning of undetermined intent A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Ceftazidime sodium 1g injection A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime sodium 1g powder for injection A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime sodium 1g/50mL injection A component that fails to comply with the current editorial guidance.
Ceftazidime sodium 20mg infusion solution 50mL vial A component that fails to comply with the current editorial guidance.
Ceftazidime sodium 2g injection A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime sodium 2g powder for injection A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime sodium 2g/50 mL conventional release solution for infusion 50mL bag A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime sodium 2g/50 mL injection A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime sodium 2g/50 mL intravenous solution 50mL bag A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime sodium 2g/50mL injection A component that is no longer current, useful, appropriate or acceptable.
Ceftibuten overdose of undetermined intent A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Ceftibuten poisoning of undetermined intent A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Ceftizoxime overdose of undetermined intent A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Ceftizoxime poisoning of undetermined intent A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Ceftizoxime sodium 10g powder for injection solution vial A component that is no longer current, useful, appropriate or acceptable.
Ceftizoxime sodium 1g powder for injection solution vial A component that is no longer current, useful, appropriate or acceptable.
Ceftizoxime sodium 20mg/mL injection solution 50mL vial A component that fails to comply with the current editorial guidance.
Ceftizoxime sodium 2g powder for injection solution vial A component that is no longer current, useful, appropriate or acceptable.
Ceftizoxime sodium 2g/vial injection A component that is no longer current, useful, appropriate or acceptable.
Ceftizoxime sodium 40mg/mL injection solution 50mL vial A component that fails to comply with the current editorial guidance.
Ceftizoxime sodium 500mg powder for injection solution vial A component that is no longer current, useful, appropriate or acceptable.
Ceftolozane and tazobactam Ambiguous
Ceftriaxone 500mg injection (pdr for recon) A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Ceftriaxone overdose of undetermined intent A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Ceftriaxone poisoning of undetermined intent A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Ceftriaxone sodium 10g powder for injection solution vial A component that is no longer current, useful, appropriate or acceptable.
Ceftriaxone sodium 1g injection A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Ceftriaxone sodium 1g injection solution 50mL bag A component that fails to comply with the current editorial guidance.
Ceftriaxone sodium 1g powder for injection A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Ceftriaxone sodium 1g/vial powder A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Ceftriaxone sodium 250mg injection A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Ceftriaxone sodium 250mg powder for injection A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Ceftriaxone sodium 2g injection A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Ceftriaxone sodium 2g injection solution 50mL bag A component that fails to comply with the current editorial guidance.
Ceftriaxone sodium 2g powder for injection A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Ceftriaxone sodium 2g/vial powder A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Ceftriaxone sodium 500mg injection A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cefuroxime 1.5g infusion (pdr for recon) A component that fails to comply with the current editorial guidance.
Cefuroxime 1.5g injection (pdr for recon) A component that fails to comply with the current editorial guidance.
Cefuroxime 1.5g injection A component that fails to comply with the current editorial guidance.
Cefuroxime 1.5g/vial powder A component that fails to comply with the current editorial guidance.
Cefuroxime 5% preservative-free eye drops Ambiguous
Cefuroxime 7.5g injection A component that fails to comply with the current editorial guidance.
Cefuroxime 750mg injection (pdr for recon) A component that fails to comply with the current editorial guidance.
Cefuroxime 750mg injection A component that fails to comply with the current editorial guidance.
Cefuroxime 750mg/vial powder A component that fails to comply with the current editorial guidance.
Cefuroxime axetil 125mg/5ml powder for suspension A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cefuroxime axetil 250mg/5 mL powder for suspension A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cefuroxime axetil 250mg/5mL powder A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cefuroxime overdose of undetermined intent A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cefuroxime poisoning of undetermined intent A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cefuroxime sodium 1.5g A component that fails to comply with the current editorial guidance.
Cefuroxime sodium 1.5g injection A component that fails to comply with the current editorial guidance.
Cefuroxime sodium 1.5g powder for injection A component that fails to comply with the current editorial guidance.
Cefuroxime sodium 1.5g/vial injection A component that fails to comply with the current editorial guidance.
Cefuroxime sodium 1.5g/vial powder A component that fails to comply with the current editorial guidance.
Cefuroxime sodium 1.5g/vl powder A component that fails to comply with the current editorial guidance.
Cefuroxime sodium 1.5mg A component that fails to comply with the current editorial guidance.
Cefuroxime sodium 1.5mg/25mL injection solution vial A component that fails to comply with the current editorial guidance.
Cefuroxime sodium 15mg/mL injection solution 50mL bag A component that is no longer current, useful, appropriate or acceptable.
Cefuroxime sodium 30mg/mL injection solution 50mL bag A component that is no longer current, useful, appropriate or acceptable.
Cefuroxime sodium 7.5g powder A component that fails to comply with the current editorial guidance.
Cefuroxime sodium 7.5g/100mL A component that fails to comply with the current editorial guidance.
Cefuroxime sodium 7.5g/vial injection A component that fails to comply with the current editorial guidance.
Cefuroxime sodium 7.5g/vial powder for injection A component that fails to comply with the current editorial guidance.
Cefuroxime sodium 7.5g/vl powder A component that fails to comply with the current editorial guidance.
Cefuroxime sodium 750mg A component that fails to comply with the current editorial guidance.
Cefuroxime sodium 750mg injection A component that fails to comply with the current editorial guidance.
Cefuroxime sodium 750mg powder A component that fails to comply with the current editorial guidance.
Cefuroxime sodium 750mg/15mL injection solution vial A component that fails to comply with the current editorial guidance.
Cefuroxime sodium 750mg/vial injection A component that fails to comply with the current editorial guidance.
Cefuroxime sodium 750mg/vial powder for injection A component that fails to comply with the current editorial guidance.
Cefuroxime sodium 750mg/vl powder A component that fails to comply with the current editorial guidance.
Cefuroxime sodium 75omg/vial injection A component that fails to comply with the current editorial guidance.
Celery RAST test A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Celevac 500mg tablet Ambiguous
Celiac and mesenteric artery injury NOS Limited component (foundation metadata concept)
Celiac and mesenteric artery injury, unspecified Limited component (foundation metadata concept)
Celiac axis and its branches Ambiguous
Celiac branch of vagus A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Celiac disease Ambiguous
Celiac disease NOS Limited component (foundation metadata concept)
Celiac infantilism Ambiguous
Celiac or mesenteric artery injury A component that fails to comply with the current editorial guidance.
Celibacy Ambiguous
Celibacy Ambiguous
Cell chromosome exam. NOS Classification derived component

Start Previous Page 231 of 1411 Next End


Reference Sets

Reference set descriptor

Back to Start